EUVIMEDEUVIMED entdecken
Open Access

Proteomic signatures as biomarkers of atherosclerosis burden

Lanyue Zhang iD, Murad Omarov iD, LingLing Xu, Barnali Das, Hong Luo, Stefanie M Hauck, Agnese Petrera, Zhi Yu, Sascha N Goonewardena, Eleftheria Zeggini, Annette Peters, Martin Dichgans iD und 3 weitere

Cardiovascular Research · 26.08.2026 · 122 (12) · 1589-1608

DOI: 10.1093/cvr/cvag140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 29.06.2026. Verfasst von Lanyue Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Medizin, LMU Munich, Feodor-Lynen-Str. 17, Munich 81377, Germany. Hauptthemen laut MEDLINE: Proteomics, Carotid Artery Diseases, Blood Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, Fritz-Thyssen Foundation, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Atherosclerosis is currently evaluated by imaging, but scalable circulating biomarkers to detect its presence and quantify overall burden are lacking. We sought to define plasma proteomic signatures that reflect the systemic burden of atherosclerosis. Methods and results In UK Biobank, we trained machine-learning models on plasma proteomics in a nested, propensity score–matched case–control sample (1666 cases; 1666 controls; Olink Explore 3072, 2920 proteins) to derive four AtheroBurden signatures: one based on the entire proteome (all 2920 proteins) and three biologically informed subsets—genetically anchored (n = 402), atherogenesis-related (n = 680), and artery-enriched (n = 248). We then computed individual-level signatures in 41 200 disease-free participants and validated their performance through (i) correlation with carotid plaque burden via ultrasound (n = 1712); (ii) prospective major adverse cardiovascular events (MACEs) prediction over 13.7 year follow-up using multivariable Cox models and incremental prediction over Systematic COronary Risk Evaluation version 2 (SCORE2) [ΔC-index; net reclassification improvement (NRI)], as well as in the external Cooperative Health Research in the Region of Augsburg (KORA) S4 (n = 1361) and Age1 (n = 796) cohorts; and (iii) longitudinal trajectories analysis in 1210 participants with 3 serial proteomic measurements. All four AtheroBurden signatures robustly discriminated prevalent atherosclerotic disease (receiver operating characteristic area under curve up to 0.91, 95% CI: 0.89–0.93) with their levels significantly increasing with the number of clinically affected vascular beds. We found significant correlations with carotid ultrasound–measured plaque burden. In prospective analysis, each signature exhibited strong associations with incident MACE [hazard ratio (HR) per standard deviation increase in whole-proteome signature: 1.75, 95% CI: 1.68–1.83; HR for Q4 vs. Q1: 3.18, 95% CI: 2.8–3.61], providing significant improvements in risk discrimination (ΔC-index: +0.044; P < 0.0001) and reclassification [NRI: 0.12 (95% CI: 0.09–0.15) at a 10% risk threshold] beyond SCORE2. These results were replicated in the KORA S4 and KORA-Age1 cohorts, where the signatures were associated with risk of future myocardial infarction and stroke. Furthermore, longitudinal analyses demonstrated steeper annual increases in proteomic signature among individuals with higher burden of vascular risk factors and individuals who experienced MACE over follow-up.

Conclusion

Plasma proteomic signatures effectively capture atherosclerotic burden and improve cardiovascular risk prediction in asymptomatic individuals. They may complement existing risk stratification by serving as a scalable and accessible blood-based screening tool to identify individuals more likely to have subclinical atherosclerosis and may benefit from confirmatory imaging and earlier prevention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsCarotid Artery DiseasesBlood ProteinsHumansBiomarkersPlaque, AtheroscleroticPredictive Value of TestsPrognosisRisk AssessmentUK BiobankFemaleMaleMiddle AgedAgedCase-Control StudiesMachine LearningTime FactorsRisk FactorsReproducibility of ResultsProspective StudiesBiological Specimen Banks

Stichwörter der Autor:innen

AtherosclerosisCardiovascular diseaseMachine learningProteomicsRisk prediction

Substanzen

BiomarkersBlood Proteins

Autor:innen und Institutionen

  • Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Medizin, LMU Munich, Feodor-Lynen-Str. 17, Munich 81377, Germany.
  • Urological Diseases Research Center, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA.
  • Institute of Epidemiology, Helmholtz Zentrum München, German Research Centre for Environmental Health (GmbH), Ingolstädter Landstr. 1, Neuherberg 85764, Germany.
  • Metabolomics and Proteomics Core, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Ingolstädter Landstr. 1, Neuherberg 85764, Germany.
  • Clinical and Translational Epidemiology Unit, Department of Medicine, Massachusetts General Hospital, 100 Cambridge Street, Boston, MA 02114, USA.
  • Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA.

ORCID-Profile: Lanyue Zhang, Murad Omarov, Martin Dichgans, Marios K Georgakis

Förderung

  • NHGRI NIH HHS
  • Fritz-Thyssen Foundation
  • German Research Foundation
  • Munich Cluster for Systems Neurology
  • Hertie Foundation
  • China Scholarship Council
  • VA MERIT
  • Taubman Medical Research Institute

Zitieren

APA

Zhang, L., Omarov, M., Xu, L., Das, B., Luo, H., Hauck, S. M., Petrera, A., Yu, Z., Goonewardena, S. N., Zeggini, E., Peters, A., Dichgans, M., Murthy, V. L., Thorand, B., & Georgakis, M. K. (2026). Proteomic signatures as biomarkers of atherosclerosis burden. Cardiovascular Research, 122(12), 1589-1608. https://doi.org/10.1093/cvr/cvag140

Vancouver

Zhang L, Omarov M, Xu L, Das B, Luo H, Hauck SM, et al. Proteomic signatures as biomarkers of atherosclerosis burden. Cardiovascular Research. 2026;122(12):1589-1608. doi:10.1093/cvr/cvag140

BibTeX
@article{Zhang2026,
  author = {Zhang, Lanyue and Omarov, Murad and Xu, LingLing and Das, Barnali and Luo, Hong and Hauck, Stefanie M and Petrera, Agnese and Yu, Zhi and Goonewardena, Sascha N and Zeggini, Eleftheria and Peters, Annette and Dichgans, Martin and Murthy, Venkatesh L and Thorand, Barbara and Georgakis, Marios K},
  title = {Proteomic signatures as biomarkers of atherosclerosis burden},
  journal = {Cardiovascular Research},
  year = {2026},
  volume = {122},
  number = {12},
  pages = {1589--1608},
  doi = {10.1093/cvr/cvag140}
}
Kostenlos starten →